ConductScience.org, home

Library / Genes

AICDA: activation induced cytidine deaminase

1 protein, 399 patents, 0 drugs, 0 trials, 4,408 NIH grants and 7,581 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolAICDAHGNC
Nameactivation induced cytidine deaminaseHGNC
NCBI Gene ID57379NCBI Gene
HGNC IDHGNC:13203HGNC
EnsemblENSG00000111732NCBI Gene
AliasesAID, ARP2, CDA2, HEL-S-284, HIGM2NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q9GZX7Single-stranded DNA cytosine deaminase1985Ensembl, GeneID, HGNCUniProt

Patents 399

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4828972 A12026-10-2816Q9GZX7Espacenet
EP 4828972 A12026-10-2820Q9GZX7Espacenet
EP 4809080 A12026-09-2386Q9GZX7Espacenet
EP 4806995 A12026-09-1632Q9GZX7Espacenet
EP 4806995 A12026-09-1634Q9GZX7Espacenet
JP 2026525611 A2026-07-3145Q9GZX7Espacenet
JP 2026525611 A2026-07-3152Q9GZX7Espacenet
JP 2026525612 A2026-07-31478Q9GZX7Espacenet
JP 2026525612 A2026-07-31485Q9GZX7Espacenet
EP 4777618 A12026-07-2216Q9GZX7Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4408

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant672,025NIH's project files
P30CA016672Cancer Center Support Grant272,025NIH's project files
R01AI072194Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation202,025NIH's project files
ZIAAR041148Mechanisms of gene expression182,025NIH's project files
P01CA234228APOBEC Mutagenesis in Cancer152,025NIH's project files
ZIABC010283DNA repair152,025NIH's project files
R01AI099195Role of ncRNA Surveillance Complex "RNA Exosome" in Class Switch Recombination and Somatic Hypermutation142,025NIH's project files
T32CA009138Molecular, Genetic and Cellular Targets of Cancer Training Program142,025NIH's project files
ZIABC010959Relationship between DNA damage detection and signaling142,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award132,025NIH's project files

Papers 7581

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42816608PubTator, text miningPubMed
42806035PubTator, text miningPubMed
42804635PubTator, text miningPubMed
42797840PubTator, text miningPubMed
42791394PubTator, text miningPubMed
42772567PubTator, text miningPubMed
42763247PubTator, text miningPubMed
42758797PubTator, text miningPubMed
42755122PubTator, text miningPubMed
42740220PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license